Assembly Biosciences (ASMB)
22.44
+0.18 (0.81%)
Upcoming Events
Latest Headlines
Form 4 ASSEMBLY BIOSCIENCES, For: Mar 29 Filed by: Gaggar Anuj
June 5, 2026 5:12 PM - SEC Filing
Form 4 ASSEMBLY BIOSCIENCES, For: Mar 29 Filed by: White Nicole S
June 5, 2026 5:11 PM - SEC Filing
Form 4 ASSEMBLY BIOSCIENCES, For: Jun 04 Filed by: McHutchison John G
June 5, 2026 5:00 PM - SEC Filing
Form 4 ASSEMBLY BIOSCIENCES, For: Jun 04 Filed by: Mahony Susan
June 5, 2026 4:50 PM - SEC Filing
Form 4 ASSEMBLY BIOSCIENCES, For: Jun 04 Filed by: Johnson-Pratt Lisa
June 5, 2026 4:45 PM - SEC Filing
Form 4 ASSEMBLY BIOSCIENCES, For: Jun 04 Filed by: Houghton Michael
June 5, 2026 4:40 PM - SEC Filing
Form 4 ASSEMBLY BIOSCIENCES, For: Jun 04 Filed by: Consylman Gina
June 5, 2026 4:35 PM - SEC Filing
Form 4 ASSEMBLY BIOSCIENCES, For: Jun 04 Filed by: ALTIG ANTHONY E
June 5, 2026 4:31 PM - SEC Filing
Form 4 ASSEMBLY BIOSCIENCES, For: Mar 29 Filed by: Bjorkquist Jeanette M
June 5, 2026 4:25 PM - SEC Filing
Form 4 ASSEMBLY BIOSCIENCES, For: Mar 29 Filed by: Delaney William E IV
June 5, 2026 4:10 PM - SEC Filing
Form 4 ASSEMBLY BIOSCIENCES, For: Mar 29 Filed by: Okazaki Jason A
June 5, 2026 4:05 PM - SEC Filing
Form 8-K ASSEMBLY BIOSCIENCES, For: Jun 04
June 5, 2026 4:00 PM - SEC Filing
Assembly Biosciences Announces Upcoming Investor Conference Presentations
May 28, 2026 4:05 PM - StreetInsider
Form 4 ASSEMBLY BIOSCIENCES, For: May 26 Filed by: GILEAD SCIENCES, INC.
May 27, 2026 8:55 PM - SEC Filing
Form SCHEDULE 13D/A ASSEMBLY BIOSCIENCES, Filed by: GILEAD SCIENCES, INC.
May 27, 2026 8:51 PM - SEC Filing
Form 8-K ASSEMBLY BIOSCIENCES, For: May 21
May 26, 2026 4:19 PM - SEC Filing
Assembly Biosciences completes $115 million stock offering
May 26, 2026 4:05 PM - StreetInsider
Assembly Biosciences Announces the Closing of its Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
May 26, 2026 4:05 PM - StreetInsider
Form 424B5 ASSEMBLY BIOSCIENCES,
May 26, 2026 6:03 AM - SEC Filing
Form 424B5 ASSEMBLY BIOSCIENCES,
May 22, 2026 4:01 PM - SEC Filing
Form 8-K ASSEMBLY BIOSCIENCES, For: May 22
May 22, 2026 7:15 AM - SEC Filing
Assembly Biosciences prices $100 million stock offering at $26.50 per share
May 22, 2026 7:05 AM - StreetInsider
Assembly Biosciences Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants
May 22, 2026 7:05 AM - Globe NewsWire
Assembly Biosciences expands ABI-6250 trials to cholestatic liver diseases
May 22, 2026 7:01 AM - StreetInsider
Assembly Biosciences Announces Expansion of ABI-6250 Clinical Development Into Cholestatic Liver Diseases
May 22, 2026 7:00 AM - StreetInsider
Assembly Biosciences to present hepatitis delta drug data at EASL congress
May 13, 2026 2:00 AM - StreetInsider
Assembly Biosciences to present hepatitis delta drug data at EASL congress
May 13, 2026 2:00 AM - StreetInsider
Assembly Biosciences to Present Topline Phase 1a Data on Hepatitis Delta Virus Entry Inhibitor ABI-6250 at the EASL Congress 2026
May 13, 2026 2:00 AM - StreetInsider
Form SCHEDULE 13G ASSEMBLY BIOSCIENCES, Filed by: Paradigm Biocapital Advisors LP
May 11, 2026 4:02 PM - SEC Filing
Assembly Biosciences to Present at the BofA Securities 2026 Global Health Care Conference
May 11, 2026 8:00 AM - Globe NewsWire
Assembly Biosciences (ASMB) Misses Q1 EPS by 54c
May 7, 2026 6:25 PM - StreetInsider
Form 10-Q ASSEMBLY BIOSCIENCES, For: Mar 31
May 7, 2026 4:20 PM - SEC Filing
Form 8-K ASSEMBLY BIOSCIENCES, For: May 07
May 7, 2026 4:14 PM - SEC Filing
Assembly Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights
May 7, 2026 4:00 PM - Globe NewsWire
Form DEFA14A ASSEMBLY BIOSCIENCES,
April 22, 2026 4:23 PM - SEC Filing
Form DEF 14A ASSEMBLY BIOSCIENCES, For: Jun 04
April 22, 2026 4:13 PM - SEC Filing
Form ARS ASSEMBLY BIOSCIENCES, For: Dec 31
April 22, 2026 4:05 PM - SEC Filing
Assembly Biosciences to present herpes drug data at ESCMID conference
April 9, 2026 8:02 AM - StreetInsider
Assembly Biosciences Highlights Presentations on Positive Phase 1b Data for ABI-5366 and ABI-1179 in Recurrent Genital Herpes at ESCMID Global 2026
April 9, 2026 8:01 AM - Globe NewsWire
Assembly Biosciences (ASMB) PT Raised to $43 at Guggenheim
April 6, 2026 6:38 AM - StreetInsider
Form 4 ASSEMBLY BIOSCIENCES, For: Mar 29 Filed by: Bjorkquist Jeanette M
March 31, 2026 4:25 PM - SEC Filing
Form 4 ASSEMBLY BIOSCIENCES, For: Mar 29 Filed by: White Nicole S
March 31, 2026 4:20 PM - SEC Filing
Form 4 ASSEMBLY BIOSCIENCES, For: Mar 29 Filed by: Gaggar Anuj
March 31, 2026 4:15 PM - SEC Filing
Form 4 ASSEMBLY BIOSCIENCES, For: Mar 29 Filed by: Delaney William E IV
March 31, 2026 4:11 PM - SEC Filing
Form 4 ASSEMBLY BIOSCIENCES, For: Mar 29 Filed by: Okazaki Jason A
March 31, 2026 4:06 PM - SEC Filing
Form 8-K ASSEMBLY BIOSCIENCES, For: Mar 24
March 30, 2026 5:37 PM - SEC Filing
Form EFFECT ASSEMBLY BIOSCIENCES,
March 30, 2026 6:08 AM - SEC Filing
Form S-3 ASSEMBLY BIOSCIENCES,
March 19, 2026 5:04 PM - SEC Filing
Form S-8 ASSEMBLY BIOSCIENCES,
March 19, 2026 4:52 PM - SEC Filing
Form 10-K ASSEMBLY BIOSCIENCES, For: Dec 31
March 19, 2026 4:17 PM - SEC Filing
Form 8-K ASSEMBLY BIOSCIENCES, For: Mar 19
March 19, 2026 4:11 PM - SEC Filing
Assembly Biosciences Reports Year-End 2025 Financial Results and Recent Highlights
March 19, 2026 4:05 PM - StreetInsider
Full Article List